This publication summarizes existing evidence on the use of antiretroviral drugs for preventing mother-to child transmission of HIV and makes recommendations on the choice of regimens in the context of expanding access to antiretroviral treatment.
This publication summarizes existing evidence on the use of antiretroviral drugs for preventing mother-to child transmission of HIV and makes recommendations on the choice of regimens in the context of expanding access to antiretroviral treatment. It is part of a series of modules comprising guidelines on care, treatment and support for HIV-infected women and their children in resource-constrained settings being developed by WHO and its partners.
It is part of a series of modules comprising guidelines on care, treatment and support for HIV-infected women and their children in resource-constrained settings being developed by WHO and its partners.
The recommendations complement revised guidelines for antiretroviral treatment that have been issued in support of the 3 by 5 Initiative. The target of treating 3 million people in developing countries with antiretroviral therapy by the end of 2005 is a necessary, achievable target on the way to the ultimate goal of universal access to antiretroviral treatment for everyone who requires it.
